Business Context and Reporting Period
This Form 8-K Current Report from Diodes Incorporated covers events occurring on May 11, 2026, specifically the results of the 2026 Annual Meeting of Stockholders and subsequent changes to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting outcomes rather than financial performance.
Material Changes and Governance Events
Director Resignation
Dr. Keh-Shew Lu, a nominee for re-election to the Board, received significantly more votes "withheld" than "for" his election. Consequently, Dr. Lu voluntarily resigned from the Board effective immediately on May 11, 2026, rather than tendering a resignation for review under the Company's policy. His resignation was voluntary and not the result of any disagreement with the Company regarding operations, policies, or practices. He will remain an employee as Special Advisor to the Chief Executive Officer.
Board Appointment
Following Dr. Lu's resignation, the Board appointed Ms. Angie Chen Button as Chairwoman of the Board on May 11, 2026.
Voting Results Summary
| Proposal | Outcome | Key Vote Counts |
|---|---|---|
| Election of Directors | 6 Elected; 1 Resigned | Dr. Lu: 3.46M For / 38.17M Withheld Other nominees received majority "For" votes. |
| Executive Compensation (Say-on-Pay) | Approved | For: 40.85M Against: 740,622 |
| Ratification of Auditor (PwC) | Approved | For: 43.75M Against: 23,923 |
Guidance, Outlook, and Risks
The filing does not contain financial guidance, outlook, or management commentary on future business performance. The primary risk disclosed relates to the significant shareholder dissent regarding Dr. Lu's re-election, which resulted in his immediate departure from the Board.
Investor Verification Checklist
- Verify the specific reasons for the high volume of "withheld" votes against Dr. Lu (38.17 million) compared to other directors.
- Confirm the transition plan for Dr. Lu's role as Special Advisor to the CEO and any potential conflicts of interest.
- Review the full proxy statement filed on April 1, 2026, for detailed background on the director nominees and compensation proposals.
- Monitor future filings for any additional changes to the Board composition or governance policies resulting from this event.